| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Vice President R&D
1 company
Lebel Francois is an Executive Vice President R&D at TCRT. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $399K at current prices.
Lebel Francois's largest disclosed position is in TCRT as Executive Vice President R&D, worth about $399K. The recent filings there lean toward selling, a net 50,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 9, 2015 | TCRT Alaunos Therapeutics, Inc. | Executive Vice President R&D | Sale+OE | 50,000 | $10.12 | $506,000.00 | -100% |